Search terms

Spectral CT 7500

Spectral-detector CT scanner

Find similar products

Philips Spectral CT 7500 provides detector-based spectral and conventional results in one scan, with always-on data and no special protocols. It supports confident diagnosis and planning across radiology, cardiology, oncology, neurology and ED/trauma, helping reduce follow-up [1] scans and streamline workflow.

Contact & support
Features
Easy workflow with always-on spectral

Easy workflow with always-on spectral

Scan as usual, complete chest-abdomen-pelvis scans in 2 seconds with no special protocols and no separate reconstructions. Spectral results ready in under 60 seconds, viewable on PACS with Spectral Magic Glass anytime.

Easy workflow with always-on spectral

Scan as usual, complete chest-abdomen-pelvis scans in 2 seconds with no special protocols and no separate reconstructions. Spectral results ready in under 60 seconds, viewable on PACS with Spectral Magic Glass anytime.

Easy workflow with always-on spectral

Scan as usual, complete chest-abdomen-pelvis scans in 2 seconds with no special protocols and no separate reconstructions. Spectral results ready in under 60 seconds, viewable on PACS with Spectral Magic Glass anytime.
Fast, confident diagnosis

Fast, confident diagnosis

Get fast insights with detector-based spectral CT, assess coronaries and myocardium in one exam and help reduce invasive and expensive procedures in the cath lab. Reduce follow-up scans by 26% [1] and diagnosis time by 34%. [2]

Fast, confident diagnosis

Get fast insights with detector-based spectral CT, assess coronaries and myocardium in one exam and help reduce invasive and expensive procedures in the cath lab. Reduce follow-up scans by 26% [1] and diagnosis time by 34%. [2]

Fast, confident diagnosis

Get fast insights with detector-based spectral CT, assess coronaries and myocardium in one exam and help reduce invasive and expensive procedures in the cath lab. Reduce follow-up scans by 26% [1] and diagnosis time by 34%. [2]
Assess coronaries and myocardium in one exam

Assess coronaries and myocardium in one exam

Assess coronaries and myocardium in a single spectral scan in under 15 minutes, including perfusion and delayed enhancement, with no added radiation dose. Visualize stents, calcified vessels, and myocardial tissue viability with enhanced clarity.[3]

Assess coronaries and myocardium in one exam

Assess coronaries and myocardium in a single spectral scan in under 15 minutes, including perfusion and delayed enhancement, with no added radiation dose. Visualize stents, calcified vessels, and myocardial tissue viability with enhanced clarity.[3]

Assess coronaries and myocardium in one exam

Assess coronaries and myocardium in a single spectral scan in under 15 minutes, including perfusion and delayed enhancement, with no added radiation dose. Visualize stents, calcified vessels, and myocardial tissue viability with enhanced clarity.[3]
Differentiate benign cysts from malignant lesions

Differentiate benign cysts from malignant lesions

With spectral dual-layer CT, the diagnostic certainty for differentiating benign cysts from malignant lesions increased to 96% (compared to 30% with conventional CT) [4], along with a 23% increase in diagnostic confidence due to improved lesion conspicuity. [5] Low MonoE spectral result enables fast lesion detection and tumor assessment, potentially avoiding multiple CT scans or other modalities.

Differentiate benign cysts from malignant lesions

With spectral dual-layer CT, the diagnostic certainty for differentiating benign cysts from malignant lesions increased to 96% (compared to 30% with conventional CT) [4], along with a 23% increase in diagnostic confidence due to improved lesion conspicuity. [5] Low MonoE spectral result enables fast lesion detection and tumor assessment, potentially avoiding multiple CT scans or other modalities.

Differentiate benign cysts from malignant lesions

With spectral dual-layer CT, the diagnostic certainty for differentiating benign cysts from malignant lesions increased to 96% (compared to 30% with conventional CT) [4], along with a 23% increase in diagnostic confidence due to improved lesion conspicuity. [5] Low MonoE spectral result enables fast lesion detection and tumor assessment, potentially avoiding multiple CT scans or other modalities.
Fast assessments in neuro and trauma

Fast assessments in neuro and trauma

Quickly differentiate gray/white matter and bleeding vs. contrast agent for faster, more accurate neuro diagnosis and treatment decisions. In trauma, rapidly assess PE and salvage suboptimal studies with enhanced contrast resolution using low MonoE spectral results [4] minimizing treatment delays.

Fast assessments in neuro and trauma

Quickly differentiate gray/white matter and bleeding vs. contrast agent for faster, more accurate neuro diagnosis and treatment decisions. In trauma, rapidly assess PE and salvage suboptimal studies with enhanced contrast resolution using low MonoE spectral results [4] minimizing treatment delays.

Fast assessments in neuro and trauma

Quickly differentiate gray/white matter and bleeding vs. contrast agent for faster, more accurate neuro diagnosis and treatment decisions. In trauma, rapidly assess PE and salvage suboptimal studies with enhanced contrast resolution using low MonoE spectral results [4] minimizing treatment delays.
Meaningful value through saved scans

Meaningful value through saved scans

Save the costs of repeat scans and contrast media and potentially avoid scans from other modalities like MRI. Gain clearer insights into complex plaque and myocardial tissue helping to streamline cardiac workflows and manage patient waitlists. Spectral CT supports risk stratification, helping reduce unnecessary cath lab procedures and has shown potential annual savings of $135K (USD) by avoiding unreimbursed confirmation scans. [1]

Meaningful value through saved scans

Save the costs of repeat scans and contrast media and potentially avoid scans from other modalities like MRI. Gain clearer insights into complex plaque and myocardial tissue helping to streamline cardiac workflows and manage patient waitlists. Spectral CT supports risk stratification, helping reduce unnecessary cath lab procedures and has shown potential annual savings of $135K (USD) by avoiding unreimbursed confirmation scans. [1]

Meaningful value through saved scans

Save the costs of repeat scans and contrast media and potentially avoid scans from other modalities like MRI. Gain clearer insights into complex plaque and myocardial tissue helping to streamline cardiac workflows and manage patient waitlists. Spectral CT supports risk stratification, helping reduce unnecessary cath lab procedures and has shown potential annual savings of $135K (USD) by avoiding unreimbursed confirmation scans. [1]
  • Easy workflow with always-on spectral
  • Fast, confident diagnosis
  • Assess coronaries and myocardium in one exam
  • Differentiate benign cysts from malignant lesions
See all features
Easy workflow with always-on spectral

Easy workflow with always-on spectral

Scan as usual, complete chest-abdomen-pelvis scans in 2 seconds with no special protocols and no separate reconstructions. Spectral results ready in under 60 seconds, viewable on PACS with Spectral Magic Glass anytime.

Easy workflow with always-on spectral

Scan as usual, complete chest-abdomen-pelvis scans in 2 seconds with no special protocols and no separate reconstructions. Spectral results ready in under 60 seconds, viewable on PACS with Spectral Magic Glass anytime.

Easy workflow with always-on spectral

Scan as usual, complete chest-abdomen-pelvis scans in 2 seconds with no special protocols and no separate reconstructions. Spectral results ready in under 60 seconds, viewable on PACS with Spectral Magic Glass anytime.
Fast, confident diagnosis

Fast, confident diagnosis

Get fast insights with detector-based spectral CT, assess coronaries and myocardium in one exam and help reduce invasive and expensive procedures in the cath lab. Reduce follow-up scans by 26% [1] and diagnosis time by 34%. [2]

Fast, confident diagnosis

Get fast insights with detector-based spectral CT, assess coronaries and myocardium in one exam and help reduce invasive and expensive procedures in the cath lab. Reduce follow-up scans by 26% [1] and diagnosis time by 34%. [2]

Fast, confident diagnosis

Get fast insights with detector-based spectral CT, assess coronaries and myocardium in one exam and help reduce invasive and expensive procedures in the cath lab. Reduce follow-up scans by 26% [1] and diagnosis time by 34%. [2]
Assess coronaries and myocardium in one exam

Assess coronaries and myocardium in one exam

Assess coronaries and myocardium in a single spectral scan in under 15 minutes, including perfusion and delayed enhancement, with no added radiation dose. Visualize stents, calcified vessels, and myocardial tissue viability with enhanced clarity.[3]

Assess coronaries and myocardium in one exam

Assess coronaries and myocardium in a single spectral scan in under 15 minutes, including perfusion and delayed enhancement, with no added radiation dose. Visualize stents, calcified vessels, and myocardial tissue viability with enhanced clarity.[3]

Assess coronaries and myocardium in one exam

Assess coronaries and myocardium in a single spectral scan in under 15 minutes, including perfusion and delayed enhancement, with no added radiation dose. Visualize stents, calcified vessels, and myocardial tissue viability with enhanced clarity.[3]
Differentiate benign cysts from malignant lesions

Differentiate benign cysts from malignant lesions

With spectral dual-layer CT, the diagnostic certainty for differentiating benign cysts from malignant lesions increased to 96% (compared to 30% with conventional CT) [4], along with a 23% increase in diagnostic confidence due to improved lesion conspicuity. [5] Low MonoE spectral result enables fast lesion detection and tumor assessment, potentially avoiding multiple CT scans or other modalities.

Differentiate benign cysts from malignant lesions

With spectral dual-layer CT, the diagnostic certainty for differentiating benign cysts from malignant lesions increased to 96% (compared to 30% with conventional CT) [4], along with a 23% increase in diagnostic confidence due to improved lesion conspicuity. [5] Low MonoE spectral result enables fast lesion detection and tumor assessment, potentially avoiding multiple CT scans or other modalities.

Differentiate benign cysts from malignant lesions

With spectral dual-layer CT, the diagnostic certainty for differentiating benign cysts from malignant lesions increased to 96% (compared to 30% with conventional CT) [4], along with a 23% increase in diagnostic confidence due to improved lesion conspicuity. [5] Low MonoE spectral result enables fast lesion detection and tumor assessment, potentially avoiding multiple CT scans or other modalities.
Fast assessments in neuro and trauma

Fast assessments in neuro and trauma

Quickly differentiate gray/white matter and bleeding vs. contrast agent for faster, more accurate neuro diagnosis and treatment decisions. In trauma, rapidly assess PE and salvage suboptimal studies with enhanced contrast resolution using low MonoE spectral results [4] minimizing treatment delays.

Fast assessments in neuro and trauma

Quickly differentiate gray/white matter and bleeding vs. contrast agent for faster, more accurate neuro diagnosis and treatment decisions. In trauma, rapidly assess PE and salvage suboptimal studies with enhanced contrast resolution using low MonoE spectral results [4] minimizing treatment delays.

Fast assessments in neuro and trauma

Quickly differentiate gray/white matter and bleeding vs. contrast agent for faster, more accurate neuro diagnosis and treatment decisions. In trauma, rapidly assess PE and salvage suboptimal studies with enhanced contrast resolution using low MonoE spectral results [4] minimizing treatment delays.
Meaningful value through saved scans

Meaningful value through saved scans

Save the costs of repeat scans and contrast media and potentially avoid scans from other modalities like MRI. Gain clearer insights into complex plaque and myocardial tissue helping to streamline cardiac workflows and manage patient waitlists. Spectral CT supports risk stratification, helping reduce unnecessary cath lab procedures and has shown potential annual savings of $135K (USD) by avoiding unreimbursed confirmation scans. [1]

Meaningful value through saved scans

Save the costs of repeat scans and contrast media and potentially avoid scans from other modalities like MRI. Gain clearer insights into complex plaque and myocardial tissue helping to streamline cardiac workflows and manage patient waitlists. Spectral CT supports risk stratification, helping reduce unnecessary cath lab procedures and has shown potential annual savings of $135K (USD) by avoiding unreimbursed confirmation scans. [1]

Meaningful value through saved scans

Save the costs of repeat scans and contrast media and potentially avoid scans from other modalities like MRI. Gain clearer insights into complex plaque and myocardial tissue helping to streamline cardiac workflows and manage patient waitlists. Spectral CT supports risk stratification, helping reduce unnecessary cath lab procedures and has shown potential annual savings of $135K (USD) by avoiding unreimbursed confirmation scans. [1]

Documentation

Whitepaper (1)

Whitepaper

Brochure (2)

Brochure

Whitepaper (1)

Whitepaper

Brochure (2)

Brochure

See all documentation

Whitepaper (1)

Whitepaper

Brochure (2)

Brochure

Specifications

General
General
Generator power
  • 120 kW
Slices
  • 512
Coverage
  • 80 mm
Rotation speed
  • 0.27 s
Maximum scannable range (axial)
  • 2,000 mm
Bore size
  • 800 mm
Conventional reconstruction speed
  • iDose4: 93% of reference protocols under 1 minute
Spectral temporal resolution
  • Simultaneous in the same time and space
kVp stations
  • Conventional: 80, 100, 120, 140; Spectral: 100, 120, 140
Spectral reconstruction speed*
  • 1-2 minutes for the majority of cases*
General
General
Generator power
  • 120 kW
Slices
  • 512
See all specifications
General
General
Generator power
  • 120 kW
Slices
  • 512
Coverage
  • 80 mm
Rotation speed
  • 0.27 s
Maximum scannable range (axial)
  • 2,000 mm
Bore size
  • 800 mm
Conventional reconstruction speed
  • iDose4: 93% of reference protocols under 1 minute
Spectral temporal resolution
  • Simultaneous in the same time and space
kVp stations
  • Conventional: 80, 100, 120, 140; Spectral: 100, 120, 140
Spectral reconstruction speed*
  • 1-2 minutes for the majority of cases*
  • Results from case studies are not predictive of results in other cases. Results in other cases may vary.
  • * Spectral reconstruction is incremental to conventional reconstruction.
  • 1. Follow-up Recommendation Rates Associated with Spectral Detector Dual-Energy CT of the Abdomen and Pelvis: A Retrospective Comparison to Single-Energy CT. Atwi, Noah E. et al. J Am Coll Radiol. 2020;17:940-950
  • 2. Philips. (2017). Whitepaper: Economic impact of IQon for patients with renal insufficiency.
  • 3.Comprehensive cardiac evaluations in under 15 minutes including coronary assessment, perfusion, and delayed enhancement studies, all without increased radiation dose. Customer story: A one-stop solution for cardiac patients using detector-based spectral CT. 4522 991 87231 * Sept 2024
  • 4. Andersen MB, Ebbesen D, Thygesen J, Kruis M, Rasmussen F. Impact of spectral body imaging in patients suspected for occult cancer: a prospective study of 503 patients. Eur Radiol. 2020 Oct;30(10):5539-5550. doi: 10.1007/s00330-020-06878-7
  • 5. Philips. (2020). Clinical Element: Improved lesion conspicuity using IQon Spectral CT.

By clicking on the link, you will be leaving the official Royal Philips ("Philips") website. Any links to third-party websites that may appear on this site are provided only for your convenience and in no way represent any affiliation or endorsement of the information provided on those linked websites. Philips makes no representations or warranties of any kind with regard to any third-party websites or the information contained therein.

I understand

You are about to visit a Philips global content page

Continue

By clicking on the link, you will be leaving the official Royal Philips ("Philips") website. Any links to third-party websites that may appear on this site are provided only for your convenience and in no way represent any affiliation or endorsement of the information provided on those linked websites. Philips makes no representations or warranties of any kind with regard to any third-party websites or the information contained therein.

I understand

You are about to visit a Philips global content page

Continue
© Koninklijke Philips N.V., 2004 - 2025. Kõik õigused reserveeritud.

Our site can best be viewed with the latest version of Microsoft Edge, Google Chrome or Firefox.

Olete sisenemas Philips HealthCare Eesti veebilehele.
Please select the checkbox

Veebilehel esitatud teave on mõeldud ainult isikutele, kes kasutavad meditsiiniseadmeid oma majandus- ja kutsetegevuses, sealhulgas tervishoiutöötajatele, tervishoiuteenuse osutajate esindajatele ning meditsiiniseadmetega oma majandus- ja kutsetegevuse raames kauplevatele isikutele. Veebilehel esitatud teave ei ole mõeldud meditsiiniliste nõuannete, ravijuhiste ega mistahes muude tervishoiualaste soovituste või suuniste andmiseks.

Kas olete isik, kes vastab ülaltoodud kriteeriumidele?

Jah Ei